AP
NASDAQ · APLM
Apollomics, Inc.
Healthcare · Biotechnology
$23.27
Down-$1.17 (-5.01%)
Updated Oct 6, 2026, 10:15 PM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 22.3M
- P/E ratio
- -0.71
- Dividend yield
- 0.00%
- 52-week range
- $3.66 – $42.12
- Volume
- 1.17K
- Avg. volume
- 23.18K
Price performance · APLM
APLM price history
1M range · 18 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
APLM closed at $23.27 after 18 trading sessions, down 5.04% for the selected period.
- Last close
- $23.27
- Period change
- -5.04%
- Period low
- $22.11
- Period high
- $24.95
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $23.00 | $23.266 | $23.00 | $23.266 | 1.17K |
| Sep 30, 2026 | $24.9498 | $24.9498 | $24.9498 | $24.9498 | 1.32K |
| Sep 29, 2026 | $22.18 | $24.67 | $22.18 | $24.1199 | 10.14K |
| Sep 28, 2026 | $23.80 | $24.50 | $23.20 | $23.845 | 2.36K |
| Sep 25, 2026 | $24.80 | $24.958 | $22.00 | $22.35 | 39.57K |
| Sep 24, 2026 | $23.48 | $23.48 | $23.48 | $23.48 | 1.31K |
| Sep 23, 2026 | $22.76 | $24.10 | $21.8838 | $23.40 | 24.96K |
| Sep 22, 2026 | $25.00 | $25.00 | $22.23 | $23.72 | 3.23K |
| Sep 21, 2026 | $23.96 | $25.00 | $23.91 | $23.91 | 2.84K |
| Sep 18, 2026 | $22.50 | $24.77 | $22.50 | $23.42 | 6.73K |
| Sep 17, 2026 | $23.00 | $24.9999 | $22.525 | $22.525 | 2.98K |
| Sep 16, 2026 | $22.615 | $22.83 | $21.59 | $22.105 | 10.34K |
| Sep 15, 2026 | $23.89 | $24.02 | $22.90 | $24.02 | 6.25K |
| Sep 14, 2026 | $23.18 | $23.18 | $23.18 | $23.18 | 503.93 |
| Sep 11, 2026 | $24.03 | $24.03 | $21.21 | $23.205 | 5.85K |
| Sep 10, 2026 | $23.90 | $24.30 | $23.75 | $23.86 | 3.82K |
| Sep 9, 2026 | $24.48 | $26.2659 | $23.965 | $24.88 | 15.94K |
| Sep 8, 2026 | $26.64 | $27.3699 | $22.80 | $24.50 | 65.87K |
Latest APLM news
The latest Smart Investors Daily articles mentioning APLM.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…
